Iridex (IRIX) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Iridex
Is Iridex a buy right now? The alternative data says hold. This IRIX stock analysis is built on the 25+ alternative data signals AltIndex tracks on Iridex every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 40/100: a Hold. The stock trades at $0.68 with a $12M market cap.
The soft spots over the past 90 days: just 40% of employees report a positive business outlook. The rest of the signal set is holding steady, which keeps IRIX at a hold rather than a sell.
IRIX’s broader alt-data profile also covers headcount (182 employees, according to LinkedIn), web traffic (10K monthly visits), and Facebook followers (9K). Every signal links to its own page with full history, the IRIX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on IRIX is just below.
Iridex AI Stock Analysis
Iridex Corporation specializes in developing and marketing innovative laser-based medical systems, primarily to treat eye disorders. Founded in 1989, the company has been a player in ophthalmology, providing products that target often-debilitating conditions such as glaucoma and retinal diseases.
Analysis generated September 4, 2026.
Recent Iridex Stock Alerts
|
Iridex | August 26 Insider Alert: Dizon Romeo R is buying shares |
|
Iridex | August 19 Price is down by -17.2% in the last 24h. |
|
Iridex | August 18 Price is up by 8% in the last 24h. |
|
Iridex | August 14 Price is up by 6.4% in the last 24h. |
Iridex Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 10K | N/A | |
| Job Posts | 0 | 100.0% | |
| LinkedIn Employees | 182 | 1.7% | |
| Employee Recommend | 59 | 0% | |
| Business Outlook | 40 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 1 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 1K | 0.8% | |
| X Followers | 253 | 0% | |
| Instagram Followers | 2K | 1.6% | |
| Facebook Followers | 9K | 0% | |
| Facebook Engagement | 2 | 66.7% |
About Iridex (IRIX)
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.
| Price | $0.68 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $12M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest Iridex News
View more →
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026August 4 - GlobeNewswire |
|
Iridex Reports First Quarter 2026 Financial ResultsMay 19 - GlobeNewswire |
|
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026May 5 - GlobeNewswire |
|
 |
Efficacy and safety of ELIOS excimer laser trabeculostomy versus iStent inject as an adjunct to phacoemulsification: a retrospective comparative studyAugust 27 - The BMJ |
 |
IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%August 25 - Biztoc.com |
See Iridex’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for IRIX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEIridex Earnings & Financial Performance
View all earnings →Iridex Insider Trading Activity
View all →| Dizon Romeo R filed to sell 164,584 shares at $0.0. Aug 24 '26 |
| Dizon Romeo R filed to sell 169,952 shares at $0.0. Aug 24 '26 |
| Dizon Romeo R filed to sell 135,975 shares at $0.0. Jun 12 '26 |
| Dizon Romeo R filed to sell 135,000 shares at $0.0. Jun 11 '26 |
| Dizon Romeo R filed to sell 133,325 shares at $0.0. Jun 8 '26 |
Iridex Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Iridex
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
SINTX TechnologiesSINT |
$1.87 2.8% | $12M | 54 |
 |
BiomericaBMRA |
$2.22 2.2% | $10M | 38 |
 |
Adagio Medical HoldingsADGM |
$0.61 0.8% | $13M | 42 |
 |
enVVeno MedicalNVNO |
$11.11 0.1% | $8M | 48 |
 |
Trinity BiotechTRIB |
$8.03 0.4% | $7M | 46 |
Explore Iridex Data
Frequently Asked Questions: Iridex (IRIX)
Iridex has an AltIndex AI Score of 40/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
40/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Iridex (IRIX) stock is $0.68 with a market cap of $12M.
As of today, Iridex’s PE (Price to Earnings) ratio is —.
View the latest Iridex insider transactions to see recent buying and selling activity by company executives and directors.
Check the Iridex congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The IRIX stock price chart above shows Iridex’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Iridex technical analysis for RSI, moving averages, and more.
See the stocks similar to Iridex section on this page for companies in the same industry ranked by market cap and AI Score.
